David S. Rampton

10.2k total citations · 1 hit paper
128 papers, 7.8k citations indexed

About

David S. Rampton is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, David S. Rampton has authored 128 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Genetics, 47 papers in Epidemiology and 44 papers in Surgery. Recurrent topics in David S. Rampton's work include Inflammatory Bowel Disease (55 papers), Microscopic Colitis (42 papers) and Helicobacter pylori-related gastroenterology studies (19 papers). David S. Rampton is often cited by papers focused on Inflammatory Bowel Disease (55 papers), Microscopic Colitis (42 papers) and Helicobacter pylori-related gastroenterology studies (19 papers). David S. Rampton collaborates with scholars based in United Kingdom, United States and Italy. David S. Rampton's co-authors include Louise Langmead, Nicola Simmonds, James Goodhand, David R. Blake, Gareth Davies, Joel Mawdsley, Tim Stevens, Roger Feakins, Mahmood Wahed and Maria Mylonaki and has published in prestigious journals such as Gastroenterology, The Journal of Physiology and Cancer.

In The Last Decade

David S. Rampton

127 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo.

1994 356 citations Gareth Davies, Nicola Simmonds et al. Gut profile →

Peers

Countries citing papers authored by David S. Rampton

Since Specialization

Citations

This map shows the geographic impact of David S. Rampton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Rampton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Rampton more than expected).

Fields of papers citing papers by David S. Rampton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Rampton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Rampton. The network helps show where David S. Rampton may publish in the future.

Co-authorship network of co-authors of David S. Rampton

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Rampton. A scholar is included among the top collaborators of David S. Rampton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Rampton. David S. Rampton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oral Iron Treatment Response and Predictors in Anaemic Adolescents and Adults with IBD: A Prospective Controlled Open-Label Trial 2016 ·Journal of Crohn s and Colitis ·David S. Rampton, James Goodhand, N Joshi, (unknown), (unknown), Farah Barakat, Lucia Macken, Douglas G. Ward, Tariq Iqbal, Jenny Epstein, John Fell, Ian R. Sanderson	15
2	Integrated Models of Care in Managing Inflammatory Bowel Disease: A Discussion 2012 ·Inflammatory Bowel Diseases ·Antonina Mikocka‐Walus, Jane M. Andrews, Çharles N. Bernstein, Lesley A. Graff, John R. Walker, Antonino Spinelli, Silvio Danese, C. Janneke van der Woude, James Goodhand, David S. Rampton, Gabriele Moser	57
3	Anxiety and psychological stress in acute severe ulcerative colitis: prevalence and effect on outcome 2011 ·Gut ·Mahmood Wahed, James Goodhand, Louise Langmead, Peter M. Irving, J Sanderson, Stuart Bloom, Sara McCartney, Joel Mawdsley, David S. Rampton	1
4	Systematic review: clostridium difficile and IBD 2011 ·Gut ·James Goodhand, William Alazawi, David S. Rampton	2
5	Application of the who fracture risk assessment tool (FRAX) to predict need for dexa scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosis 2011 ·Gut ·James Goodhand, (unknown), Hai Viet Nguyen, Mahmood Wahed, David S. Rampton	4
6	The Influence of Stress on the Development and Severity of Immune-Mediated Diseases 2011 ·PubMed ·David S. Rampton	43
7	Differential regulation of interleukin 17 and interferon production in inflammatory bowel disease 2009 ·Gut ·L. Rovedatti, Takahiro Kudo, Paolo Biancheri, Massimiliano Sarra, Charles H. Knowles, David S. Rampton, Gino Roberto Corazza, Giovanni Monteleone, Antonio Di Sabatino, Thomas T. MacDonald	271
8	Does psychological counseling alter the natural history of inflammatory bowel disease? 2009 ·Inflammatory Bowel Diseases ·Mahmood Wahed, (unknown), James Goodhand, David S. Rampton	50
9	Blockade of transforming growth factor β upregulates T-box transcription factor T-bet, and increases T helper cell type 1 cytokine and matrix metalloproteinase-3 production in the human gut mucosa 2008 ·Gut ·Antonio Di Sabatino, K. Pickard, David S. Rampton, Laurens Kruidenier, L. Rovedatti, N. Leakey, Gino Roberto Corazza, Giovanni Monteleone, Thomas T. MacDonald	83
10	Thromboxane synthase immunohistochemistry in inflammatory bowel disease 2002 ·Journal of Clinical Pathology ·E Carty, (unknown), Roger Feakins, David S. Rampton	19
11	Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system 1999 ·Cytometry ·M. G. Macey, E Carty, Lee Webb, Emma Chapman, David Zelmanovic, David Okrongly, David S. Rampton, Adrian C. Newland	69
12	Diversion colitis: a trigger for ulcerative colitis in the in-stream colon? 1999 ·Gut ·(unknown), (unknown), Roger Feakins, David S. Rampton	23
13	Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. 1996 ·Gut ·Andrew Millar, David S. Rampton, C. L. Chander, A. Claxson, S. Blades, A Coumbe, (unknown), Christopher J. Morris, David R. Blake	261
14	Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease. 1995 ·Gut ·G. Schürmann, A.E. Bishop, P. Facer, Michele Del Vecchio, (unknown), David S. Rampton, J. M. Polak	85
15	High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. 1994 ·Gut ·Nick Banatvala, Gareth Davies, Y. Abdi, (unknown), David S. Rampton, J. M. Hardie, Ricardo A. Feldman	92
16	Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. breakdown → 1994 ·Gut ·Gareth Davies, Nicola Simmonds, Tim Stevens, M. Sheaff, Nick Banatvala, Ian F. Laurenson, David R. Blake, David S. Rampton	356
17	Increased leukotriene B4 release from ileal pouch mucosa in ulcerative colitis compared with familial adenomatous polyposis. 1994 ·Gut ·D J Gertner, David S. Rampton, Michael Madden, I C Talbot, R J Nicholls, J E Lennard-Jones	29
18	Relationship between Infective Load of Helicobacter pylori and Reactive Oxygen Metabolite Production in Antral Mucosa 1994 ·Scandinavian Journal of Gastroenterology ·Gareth Davies, Nick Banatvala, Claire Collins, M. Sheaff, Y. Abdi, (unknown), David S. Rampton	111
19	Stress proteins in colorectal mucosa 1993 ·Digestive Diseases and Sciences ·V R Winrow, (unknown), Stephen Ryder, Jonathan M. Rhodes, David R. Blake, David S. Rampton	28
20	Mucosal reactive oxygen metabolite production in duodenal ulcer disease. 1992 ·Gut ·Gareth Davies, Nicola Simmonds, Tim Stevens, Alistair S. Grandison, David R. Blake, David S. Rampton	109

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact